Ercros Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FOSFOMYCIN TROMETHAMINE, with a corresponding US DMF Number 31195.
Remarkably, this DMF maintains an Active status since its submission on February 24, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 20, 2017, and payment made on December 22, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II